Date: August 06, 2026
Background
- Scheme of Amalgamation between Medinova Diagnostic Services Limited (Transferor Company) and Vijaya Diagnostic Centre Limited (Transferee Company) sanctioned by NCLT Hyderabad Bench
- Share exchange ratio: 1 VDCL share for every 22 MDSL shares held
- Record Date: November 25, 2025
- Allotment Date: January 8, 2026
- Fractional entitlements aggregated to 3,914 equity shares of face value ₹1 each
Fractional Entitlement Treatment
- 3,914 fractional shares sold on June 22, 2026
- Average selling price: ₹1,328.027 per share
- Gross proceeds: ₹51,97,897.68
- Deductions: ₹12,994.85 (applicable taxes and expenses)
- Net sale proceeds: ₹51,84,902.83
Distribution Details
- Distribution date: August 05, 2026
- Amount distributed to shareholders: ₹14,99,575.99
- Amount maintained in escrow account (HDFC Bank A/c 50200118300305): ₹36,85,326.84
- Total eligible shareholders amount: ₹51,84,902.83
Escrow Account Management
- Funds held for shareholders with invalid, unavailable, or incomplete bank details
- Company undertakes to trace shareholders and remit amounts within 7 years
- Unclaimed amounts after 7 years to be transferred to Investor Education and Protection Fund
Certifications
- Audit Committee certification dated August 6, 2026 signed by S. Suprita Reddy (DIN: 00263618)
- Independent Directors certification dated August 6, 2026 signed by Ravi Shankararamiah (DIN: 00180746)
- Compliance with SEBI Master Circular No. SEBI/HO/CFD/POD-2/P/CIR/2023/93 dated June 20, 2023
- Compliance with Clause 15 of the Scheme of Amalgamation